Oxford Immunotec Global PLC 4
4 · Oxford Immunotec Global PLC · Filed Mar 6, 2017
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Award
Ordinary Shares
2017-02-24+8,551→ 52,893 total - Award
Stock Option (Right to Buy)
2017-02-24+38,838→ 38,838 totalExercise: $13.50Exp: 2027-02-24→ Ordinary Shares (38,838 underlying)
Footnotes (2)
- [F1]Option granted under Issuer's 2013 Share Incentive Plan.
- [F2]Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2018 through January 1, 2021.